{"title": "Comparison of the coronavirus pandemic dynamics in Europe, USA and South Korea", "doi": "10.1101/2020.03.18.20038133", "citation_id": "2020.03.18.20038133v1", "date": "2020-03-20", "laguage": "en", "journal_title": "medRxiv", "first_page": "2020.03.18.20038133", "abstract": "<p>The pandemic cased by coronavirus COVID-19 is of great concern. A detailed scientific analysis of this phenomenon is still to come, but now it is urgently needed to evaluate the disease dynamics in order to organize the appropriate quarantine activities, to estimate the required number of places in hospitals, the level of individual protection, the rate of isolation of infected persons, etc. South Korea has achieved the stabilization of  the number of cases at rather low level. The epidemic dynamics there can be compared with its development in other countries to make some preliminary, but very important conclusions. Here we provide a simple method of data comparison that can be useful for both governmental organizations and anyone.</p>", "twitter_description": "The pandemic cased by coronavirus COVID-19 is of great concern. A detailed scientific analysis of this phenomenon is still to come, but now it is urgently needed to evaluate the disease dynamics in order to organize the appropriate quarantine activities, to estimate the required number of places in hospitals, the level of individual protection, the rate of isolation of infected persons, etc. South Korea has achieved the stabilization of the number of cases at rather low level. The epidemic dynamics there can be compared with its development in other countries to make some preliminary, but very important conclusions. Here we provide a simple method of data comparison that can be useful for both governmental organizations and anyone.\n\n### Competing Interest Statement\n\nThe authors have declared no competing interest.\n\n### Funding Statement\n\nno funding\n\n### Author Declarations\n\nAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.\n\nYes\n\nAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.\n\nYes\n\nI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).\n\nYes\n\nI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.\n\nYes\n\nAll data are in the text", "full_text_html_url": "https://www.medrxiv.org/content/10.1101/2020.03.18.20038133v1.full", "public_url": "https://www.medrxiv.org/content/10.1101/2020.03.18.20038133v1", "abstract_html_url": "https://www.medrxiv.org/content/10.1101/2020.03.18.20038133v1.abstract", "pdf_url": "https://www.medrxiv.org/content/medrxiv/early/2020/03/20/2020.03.18.20038133.full.pdf", "rights": "\u00a9 2020, Posted by Cold Spring Harbor Laboratory. The copyright holder for this pre-print is the author. All rights reserved. The material may not be redistributed, re-used or adapted without the author's permission.", "publisher": "Cold Spring Harbor Laboratory Press", "pisa": "medrxiv;2020.03.18.20038133v1", "access_rights": "restricted", "authors": ["Igor Nesteruk"]}